SELF-TEST FOR GLUCOSE - ANVISA Registration 81414020030

Access comprehensive regulatory information for SELF-TEST FOR GLUCOSE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81414020030 and manufactured by ROCHE DIABETES CARE GMBH. The registration is held by ROCHE DIABETES CARE BRASIL LTDA with validity until Jun 24, 2033.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including OK BIOTECH CO., LTD., ROCHE DIABETES CARE GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81414020030
2 Related Devices
Registration Details
ANVISA Registration Number: 81414020030
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Accu-Chek Active
Risk Class III

Registration Details

81414020030

25351369277201788

23552212000187

Company Information

Germany
PT: ALEMANHA

Dates and Status

Aug 28, 2017

24/06/2033

09/18/2025 19:00:01

Accu-Chek Active
Risk Class III

Registration Details

81414020030

25351369277201788

23552212000187

Company Information

Dates and Status

Aug 28, 2017

24/06/2033

09/18/2025 19:00:01